Advances in the Understanding of Complement Mediated Glomerular Disease: Implications for Recurrence in the Transplant Setting

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|15|2|312-319

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.2, 2015-02, pp. : 312-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate Mofetil and Post-Transplant Glomerular Disease

By  

Nephron Clin Pract, Vol. 98, Iss. 3, 2004-11 ,pp. : c59-c60

Karger

Access to resources Recommend Favorite

Treatment of Hepatitis C-Mediated Glomerular Disease

By  

Nephron Clin Pract, Vol. 119, Iss. 2, 2011-07 ,pp. : c121-c130

Karger

Access to resources Recommend Favorite

Biodegradable Microparticles for in vivo Glomerular Targeting: Implications for Gene Therapy of Glomerular Disease

By Nahman Jr. N.S.  

Biomedical Microdevices, Vol. 4, Iss. 3, 2002-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Complement and Glomerular Diseases

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 238-242

Karger

Access to resources Recommend Favorite

Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 51-57

John Wiley & Sons Inc

Access to resources Recommend Favorite